brand logo

Am Fam Physician. 2024;109(3):277-278

Author disclosure: No relevant financial relationships.

TestIndicationPopulationCost*
DermTech Pigmented Lesion AssayA noninvasive test to guide biopsy decisions for atypical, pigmented lesions meeting at least one ABCDE criteria for melanomaAdults 18 years and older with Fitzpatrick skin types I through III$760

The DermTech Pigmented Lesion Assay (PLA) is a noninvasive test used for the detection of melanoma. Adhesive stickers are used to collect skin cells from the entire surface of suspicious melanocytic lesions that have one or more ABCDE criteria for melanoma. These stickers are analyzed for genomic markers associated with melanoma: RNA (LINC00518 and PRAME) and optional add-on DNA (TERT). When results are positive for one or more genomic markers, a biopsy is recommended. If results are negative for genomic markers, biopsy deferral and continued monitoring of the lesion are recommended.1 The PLA has not been approved by the U.S. Food and Drug Administration.1

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

This series is coordinated by Natasha Pyzocha, DO, contributing editor.

A collection of Diagnostic Tests published in AFP is available at https://www.aafp.org/afp/diagnostic.

Continue Reading

More in AFP

More in PubMed

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.